Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

May 18, 2023
Taiho Pharmaceutical

Taiho Pharmaceutical Enters into a Clinical Trial Agreement with Arcus Biosciences and Gilead Sciences
May 11, 2023
Otsuka Pharmaceutical

Otsuka and Lundbeck Announce U.S. Food and Drug Administration (FDA) Approval of Supplemental New Drug Application (sNDA) for REXULTI® (brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer’s Disease
May 8, 2023
Otsuka Chemical

SynCrest Launches CRDMO Service for Peptide-based Therapeutics - Integrated support across the drug development value chain with continuous flow synthesis -
May 2, 2023
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory completes acquisition of additional equity in its joint venture subsidiary, Otsuka Pharmaceutical India Private Limited
April 28, 2023
Otsuka Pharmaceutical

FDA Approves Otsuka and Lundbeck’s ABILIFY ASIMTUFII® (aripiprazole), the First, Two-month, Long-acting Injectable (LAI) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults
April 27, 2023
Taiho Pharmaceutical

CHMP ISSUES POSITIVE OPINION FOR FUTIBATINIB FOR THE TREATMENT OF ADULTS WITH CHOLANGIOCARCINOMA
April 19, 2023
Taiho Pharmaceutical

U.S. Food and Drug Administration Accepts for Priority Review Supplemental New Drug Application for the Use of Trifluridine/Tipiracil (LONSURF®) in Combination With Bevacizumab for Refractory Metastatic Colorectal Cancer
April 17, 2023
Otsuka Pharmaceutical

Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on brexpiprazole for the Treatment of Agitation Associated with Alzheimer's Dementia
March 30, 2023
Otsuka Holdings

Otsuka Holdings appoints Board Members and Audit & Supervisory Board Members
March 22, 2023
Otsuka HoldingsOtsuka Pharmaceutical

Otsuka Holdings Selected as Nadeshiko Brand for FY 2022
March 10, 2023
Otsuka HoldingsOtsuka Foods

Otsuka Foods Announces Personnel Changes
March 8, 2023
Otsuka Foods

Otsuka Foods to Launch New My Size Wholecare Series Delicious, Satisfying, and with Clear Labelling of the Amounts of the Nutrients People Especially Care About Available at Drugstores, Pharmacies and Other Outlets Nationwide Starting March 14
March 8, 2023
Otsuka Foods

Otsuka Foods to Release MATCH Salty Lemon Soda in a 500ml PET Bottle and MATCH Jelly Muscat in a 260g PET Bottle Great for Refreshing and Recharging on Sodium Electrolytes after High School Sports Activities and Studying In Stores across Japan from March 27, 2023
March 7, 2023
Otsuka Pharmaceutical

New SOYJOY Fruits & Cheese Baked cheesecake-flavored whole-soy nutrition bar with ample fruit
March 7, 2023
Taiho Pharmaceutical

Disinfect Your Mouth While Going about Your Day Taiho Pharmaceutical Offers PITAS Medical Troche Via Its Online Shop on March 7
March 3, 2023
Otsuka Pharmaceutical

Introducing New UL?OS Scalp Shampoo Volume-up Addresses men’s scalp condition and hair problems
March 1, 2023
Otsuka Chemical

Otsuka Chemical and Yokogawa Electric to Launch SynCrest Inc., a Joint Venture Targeting the CRDMO Business for Middle-molecular Drugs
March 1, 2023
Otsuka Pharmaceutical

New EQUELLE gelée, an Extension of the EQUELLE Brand A convenient, smart solution for midlife transitions
February 24, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical an Official Partner of Tokyo Marathon 2023 Providing health management support for runners and officials
February 10, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical Finalizes Agreement with Naruto City and Toyota Tsusho Corporation to Promote Horizontal Recycling of PET bottles
February 8, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical Receives “Consumer-oriented Activity Award” at the 8th ACAP Consumer-oriented Activity Awards - Recognized for ongoing women’s health-care initiatives-
January 31, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical Installs Solar Power Generation Systems at Takasaki and Tokushima Itano Factories -Targeting reduction of CO2 emissions-
January 30, 2023
Otsuka Pharmaceutical

Otsuka Applies for the Additional Indication of Adjunctive Treatment of Major Depressive Disorder for Rexulti® (brexpiprazole) in Japan
January 10, 2023
Otsuka Foods

Bon Curry Certified by Guinness World Records™ as the World’s Longest-Selling Retort-Pouch Curry Brand Bon Curry Celebrates 55th Anniversary This Year
January 10, 2023
Otsuka Pharmaceutical

Otsuka and Lundbeck announce FDA acceptance and priority review of sNDA for brexpiprazole for the treatment of agitation associated with Alzheimer’s dementia
January 10, 2023
Otsuka Pharmaceutical

Otsuka and Schrödinger Announce Single-Target, Drug Discovery Collaboration in Neurology
December 26, 2022
Otsuka Medical Devices

Otsuka Medical Devices has entered into an exclusive agreement with CSI to distribute Diamondback 360 Coronary Orbital Atherectomy System in Japan
December 13, 2022
Otsuka Holdings

Otsuka Group Selected for CDP Climate Change A List
December 12, 2022
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory launches Lilium one, a medical device that measures urine volume in the bladder specialized for single measurement
December 6, 2022
Otsuka Pharmaceutical

Announcement of Price Revisions for Specified Products

Otsuka Group News

First 30 results